BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9667267)

  • 1. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.
    Scheurlen WG; Schwabe GC; Joos S; Mollenhauer J; Sörensen N; Kühl J
    J Clin Oncol; 1998 Jul; 16(7):2478-85. PubMed ID: 9667267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic and histopathologic studies of congenital supratentorial primitive neuroectodermal tumors: a case report.
    Girschick HJ; Klein R; Scheurlen WG; Kühl J
    Pathol Oncol Res; 2001; 7(1):67-71. PubMed ID: 11349224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene aberrations in childhood brain tumors.
    Kucerová H; Stejskalová E; Vícha A; Tichý M; Chánová M; Sumerauer D; Koutechký J; Eckschlager T
    Folia Biol (Praha); 2000; 46(5):187-90. PubMed ID: 11055797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11.2.
    Scheurlen WG; Seranski P; Mincheva A; Kühl J; Sörensen N; Krauss J; Lichter P; Poustka A; Wilgenbus KK
    Genes Chromosomes Cancer; 1997 Jan; 18(1):50-8. PubMed ID: 8993980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
    Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
    J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
    Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
    J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
    Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
    Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
    Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis and loss of heterozygosity of PEDF in central nervous system primitive neuroectodermal tumors.
    Slavc I; Rodriguez IR; Mazuruk K; Chader GJ; Biegel JA
    Int J Cancer; 1997 Jul; 72(2):277-82. PubMed ID: 9219833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.
    Perry A; Miller CR; Gujrati M; Scheithauer BW; Zambrano SC; Jost SC; Raghavan R; Qian J; Cochran EJ; Huse JT; Holland EC; Burger PC; Rosenblum MK
    Brain Pathol; 2009 Jan; 19(1):81-90. PubMed ID: 18452568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
    Frühwald MC; O'Dorisio MS; Rush LJ; Reiter JL; Smiraglia DJ; Wenger G; Costello JF; White PS; Krahe R; Brodeur GM; Plass C
    J Med Genet; 2000 Jul; 37(7):501-9. PubMed ID: 10882752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.
    Grotzer MA; Janss AJ; Fung K; Biegel JA; Sutton LN; Rorke LB; Zhao H; Cnaan A; Phillips PC; Lee VM; Trojanowski JQ
    J Clin Oncol; 2000 Mar; 18(5):1027-35. PubMed ID: 10694553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the TP53 gene in human gliomas.
    Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
    Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.
    Raffel C; Gilles FE; Weinberg KI
    Cancer Res; 1990 Feb; 50(3):587-91. PubMed ID: 1967549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
    Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
    Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenicity of cerebellar primitive neuro-ectodermal tumors in athymic mice correlates with poor prognosis in children.
    Vassal G; Terrier-Lacombe MJ; Lellouch-Tubiana A; Valery CA; Sainte-Rose C; Morizet J; Ardouin P; Riou G; Kalifa C; Gouyette A
    Int J Cancer; 1996 Apr; 69(2):146-51. PubMed ID: 8608984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular abnormalities in pediatric embryonal brain tumors--analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22.
    Zakrzewska M; Rieske P; Debiec-Rychter M; Zakrzewski K; Polis L; Fiks T; Liberski PP
    Clin Neuropathol; 2004; 23(5):209-17. PubMed ID: 15581023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.